Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

BACILLIGEN — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report (No Activity)

BACILLIGEN

via GATEWAY CONSULTING, LLC

2nd Quarter (Apr 1 - June 30) · 2008Posted Jul 8, 2008Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: BACILLIGEN
Description: biotechnology/pharmaceutical firm
Location: Maryland · United States of America

Registrant

Firm: GATEWAY CONSULTING, LLC
Description: government relations, public affairs
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.